» Articles » PMID: 38868235

Ab Interno Intraluminal Stent Insertion for Prolonged Hypotony After PreserFlo MicroShunt Implantation

Overview
Journal Cureus
Date 2024 Jun 13
PMID 38868235
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to present an effective and minimally invasive method for treating prolonged hypotony after PreserFlo MicroShunt (PMS) implantation, which can cause serious complications. A 79-year-old man with primary open-angle glaucoma of the right eye underwent ab interno intraluminal stent insertion for prolonged hypotony after PMS implantation. After making two corneal incisions at the 5 and 8 o'clock positions in the right eye, a viscoelastic material was injected into the anterior chamber. A 10-0 nylon suture was inserted into the anterior chamber through a corneal incision in the 5 o'clock position. Next, the 10-0 nylon suture was grasped and inserted into the PMS lumen as a stent with forceps, following which it was cut approximately 1 mm from the tip of the PMS using micro-iris scissors. Finally, the viscoelastic material in the anterior chamber was washed with a balanced salt solution, and self-closure of the two corneal incisions was confirmed. After ab interno intraluminal stent insertion, hypotony improved and stabilized at approximately 10 mmHg. The shallow anterior chamber, choroidal detachment, and hypotonic maculopathy improved rapidly. This novel technique demonstrated effectiveness and minimal invasiveness in treating prolonged hypotony after PMS implantation.

Citing Articles

Risk factors and protective strategies for hypotony following preserflo microshunt implantation.

Mieno H, Mori K, Yoshii K, Okada Y, Ikeda Y, Ueno M Sci Rep. 2025; 15(1):8344.

PMID: 40069337 PMC: 11897240. DOI: 10.1038/s41598-025-92879-9.


Comparison of outcomes with and without intrastent placement during PMS surgery.

Miura Y, Fukuda K, Yamashiro K Sci Rep. 2025; 15(1):2981.

PMID: 39849053 PMC: 11758089. DOI: 10.1038/s41598-025-87259-2.


Intraluminal Insertion of 9-0 Nylon for Postoperative Choroidal Detachment After Preserflo MicroShunt Implantation: A Case Report.

Kitamura Y, Ikema S, Tatsumi T, Baba T Cureus. 2024; 16(11):e74560.

PMID: 39735092 PMC: 11676401. DOI: 10.7759/cureus.74560.

References
1.
Beckers H, Aptel F, Webers C, Bluwol E, Martinez-de-la-Casa J, Garcia-Feijoo J . Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study. Ophthalmol Glaucoma. 2021; 5(2):195-209. DOI: 10.1016/j.ogla.2021.07.008. View

2.
Pinchuk L, Riss I, Batlle J, Kato Y, Martin J, Arrieta E . The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater. 2015; 105(1):211-221. PMC: 5215625. DOI: 10.1002/jbm.b.33525. View

3.
Tanner A, Haddad F, Fajardo-Sanchez J, Nguyen E, Thong K, Ah-Moye S . One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis. Br J Ophthalmol. 2022; 107(8):1104-1111. PMC: 10359526. DOI: 10.1136/bjophthalmol-2021-320631. View

4.
Batlle J, Corona A, Albuquerque R . Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study. J Glaucoma. 2020; 30(3):281-286. PMC: 8041565. DOI: 10.1097/IJG.0000000000001734. View

5.
Baker N, Barnebey H, Moster M, Stiles M, Vold S, Khatana A . Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study. Ophthalmology. 2021; 128(12):1710-1721. DOI: 10.1016/j.ophtha.2021.05.023. View